Wu R - Search Results

1

A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma.

Chen L, Wang Y, Liu F, Xu L, Peng F, Zhao N, Fu B, Zhu Z, Shi Y, Liu J, Wu R, Wang C, Yao S, Li Y. Chen L, et al. Among authors: wu r. Sci Rep. 2018 Jan 23;8(1):1439. doi: 10.1038/s41598-018-19949-z. Sci Rep. 2018. PMID: 29362385 Free PMC article. Review.

2

Phase II clinical trial of h-R3 combined with radiotherapy in locally advanced nasopharyngeal carcinoma.

Wu RR, Xiao ZY, Wang C, Liu HF, Zhong H, Li F. Wu RR, et al. J BUON. 2014 Oct-Dec;19(4):930-6. J BUON. 2014. PMID: 25536598 Free article. Clinical Trial.

3

LncRNA GAS5/miR‑4465 axis regulates the malignant potential of nasopharyngeal carcinoma by targeting COX2.

Zhong Q, Wang Z, Liao X, Wu R, Guo X. Zhong Q, et al. Among authors: wu r. Cell Cycle. 2020 Nov;19(22):3004-3017. doi: 10.1080/15384101.2020.1816280. Epub 2020 Oct 23. Cell Cycle. 2020. PMID: 33092435 Free PMC article. Retracted.

4

MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-β signaling pathway.

Wu R, Zhong Q, Liu H, Liu S. Wu R, et al. Chem Biol Drug Des. 2023 Oct;102(4):815-827. doi: 10.1111/cbdd.14293. Epub 2023 Jul 27. Chem Biol Drug Des. 2023. PMID: 37500510

5

Molecular mechanism of FBXW7-mediated ubiquitination modification in nasopharyngeal carcinoma cell proliferation in vitro and in vivo.

Zhong Q, Wang Z, Kang H, Wu R. Zhong Q, et al. Among authors: wu r. Pathol Res Pract. 2023 Apr;244:154056. doi: 10.1016/j.prp.2022.154056. Epub 2022 Aug 3. Pathol Res Pract. 2023. PMID: 36989847

6

Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway.

Zhong Q, Nie Q, Wu R, Huang Y. Zhong Q, et al. Among authors: wu r. Cell Cycle. 2023 Jul;22(13):1544-1562. doi: 10.1080/15384101.2023.2216508. Epub 2023 Jun 7. Cell Cycle. 2023. PMID: 37287276

7

Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients.

Zhong Q, Zhong Q, Cai X, Wu R. Zhong Q, et al. Among authors: wu r. Genes Genomics. 2023 Sep;45(9):1211-1226. doi: 10.1007/s13258-023-01413-6. Epub 2023 Jun 10. Genes Genomics. 2023. PMID: 37301776

8

Circular RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote the growth of nasopharyngeal carcinoma.

Zhong Q, Huang J, Wei J, Wu R. Zhong Q, et al. Among authors: wu r. Cancer Cell Int. 2019 Oct 1;19:252. doi: 10.1186/s12935-019-0959-y. eCollection 2019. Cancer Cell Int. 2019. PMID: 31582908 Free PMC article.

9

[Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma].

Huang XD, Yi JL, Gao L, Xu GZ, Jin J, Yang WZ, Lu TX, Wu SX, Wu RR, Hu WH, Xie WC, Han F, Gao YH, Gao JM, Pan JJ, Chen CB, Lang JY, Li T, Dong Y, Fu YB, Fan L, Li BS, Li J, Wang XH, Chen BX, Gao XS, Zhang P, Wu XW, Hu BQ. Huang XD, et al. Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):197-201. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17649636 Clinical Trial. Chinese.

10

No genetic causal association between iron status and pulmonary artery hypertension: Insights from a two-sample Mendelian randomization.

Liu PC, Lv MN, Rong YY, Yu SJ, Wu R. Liu PC, et al. Among authors: wu r. Pulm Circ. 2024 Apr 17;14(2):e12370. doi: 10.1002/pul2.12370. eCollection 2024 Apr. Pulm Circ. 2024. PMID: 38774814 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,084 results

Search Page